LXEO Latest Press Releases

-- May 19, 2026 --

Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference Globe Newswire 7:00 AM

-- May 11, 2026 --

Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights Globe Newswire 7:00 AM

-- April 27, 2026 --

Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Globe Newswire 5:15 PM

-- March 30, 2026 --

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights Globe Newswire 4:05 PM

-- March 3, 2026 --

Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference Globe Newswire 7:30 AM

-- February 5, 2026 --

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February Globe Newswire 7:30 AM

-- January 27, 2026 --

Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics Globe Newswire 7:30 AM

-- January 12, 2026 --

Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy Globe Newswire 7:00 AM

-- January 8, 2026 --

Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software